Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.020
-0.090 (-4.27%)
At close: Jun 10, 2025, 4:00 PM
2.100
+0.080 (3.96%)
After-hours: Jun 10, 2025, 7:45 PM EDT
Aytu BioPharma Employees
Aytu BioPharma had 102 employees as of June 30, 2024. The number of employees decreased by 48 or -32.00% compared to the previous year.
Employees
102
Change (1Y)
-48
Growth (1Y)
-32.00%
Revenue / Employee
$800,578
Profits / Employee
$16,069
Market Cap
12.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AYTU News
- 1 day ago - Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan - Accesswire
- 4 days ago - Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock - Accesswire
- 4 days ago - Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States - Accesswire
- 27 days ago - Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results - Accesswire
- 4 weeks ago - Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025 - Accesswire
- 7 weeks ago - Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - Accesswire
- 4 months ago - Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript - Seeking Alpha